Li, Yuan

Epidermal growth factor receptor transactivation by endogenous vasoactive peptides contributes to hyperproliferation of vascular smooth muscle cells of SHR. [electronic resource] - American journal of physiology. Heart and circulatory physiology Dec 2010 - H1959-67 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1522-1539

10.1152/ajpheart.00526.2010 doi


Angiotensin II--metabolism
Angiotensin II Type 1 Receptor Blockers--pharmacology
Animals
CSK Tyrosine-Protein Kinase
Cell Proliferation--drug effects
Cells, Cultured
Disease Models, Animal
Endothelin A Receptor Antagonists
Endothelin B Receptor Antagonists
Endothelin-1--metabolism
Enzyme Inhibitors--pharmacology
Epidermal Growth Factor--antagonists & inhibitors
ErbB Receptors--metabolism
Free Radical Scavengers--pharmacology
Hyperplasia
Hypertension--metabolism
Mitogen-Activated Protein Kinases--metabolism
Muscle, Smooth, Vascular--drug effects
Myocytes, Smooth Muscle--drug effects
NADPH Oxidases--antagonists & inhibitors
Oxidative Stress
Phosphorylation
Protein-Tyrosine Kinases--antagonists & inhibitors
Rats
Rats, Inbred SHR
Rats, Inbred WKY
Receptor, Angiotensin, Type 1--drug effects
Receptor, Endothelin A--metabolism
Receptor, Endothelin B--metabolism
Signal Transduction
Superoxides--metabolism
src-Family Kinases